MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

This expansion of our Durham plant is a crucial component of the more than $12 billion Merck has invested toward U.S. capital ...

MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to produce the bulk drug substance for its HPV vaccine Gardasil.

Their CryptoMap platform leverages immunopeptidomics, genomics, and a bioinformatics pipeline, allowing the identification of ...

Merck & Co. (MSD outside the U.S. and Canada) has just unveiled a brand-new, cutting-edge vaccine manufacturing facility at ...

Merck opens new, $1 billion, 225,000-sq ft facility dedicated to vaccine manufacturing at its Durham, North Carolina, site: Durham, North Carolina Wednesday, March 12, 2025, 09:00 ...

Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its ...

Drugmaker Merck , known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the year, a senior company executive said on Wednesday.

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

Opening highlights effort to expand U.S. manufacturing through a $1 billion investment Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new ...